Amdocs Stock Today

DOX Stock  USD 91.03  1.17  1.27%   

Performance

8 of 100

 
Low
 
High
OK

Odds Of Distress

Less than 8

 
100  
 
Zero
Low
Amdocs is trading at 91.03 as of the 19th of March 2024; that is -1.27 percent decrease since the beginning of the trading day. The stock's open price was 92.2. Amdocs has only a 8 % chance of going through financial distress over the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Amdocs are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of November 2022 and ending today, the 19th of March 2024. Click here to learn more.
Business Domain
Software & Services
IPO Date
19th of June 1998
Category
Technology
Classification
Information Technology
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. The company has 116.5 M outstanding shares of which 1.71 M shares are currently shorted by investors with about 2.23 days to cover. More on Amdocs

Moving against Amdocs Stock

  0.8EGIO Edgio Inc Report 17th of July 2024 PairCorr
  0.68BB BlackBerry Report 4th of April 2024 PairCorr
  0.54VRSN VeriSign Financial Report 25th of April 2024 PairCorr
  0.52EVCM EverCommerce Report 20th of March 2024 PairCorr
  0.51FIVN Five9 Inc Financial Report 2nd of May 2024 PairCorr
  0.45MQ Marqeta Financial Report 14th of May 2024 PairCorr

Amdocs Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amdocs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amdocs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Amdocs' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Amdocs' managers, analysts, and investors.
Environment Score
Governance Score
Social Score
CEO PresidentJoshua Sheffer
Thematic IdeaIsrael Wall Street (View all Themes)
Old NameDorex Minerals Inc.
Business ConcentrationIT Consulting & Other Services, Software - Infrastructure, Information Technology, NASDAQ Composite, NASDAQ Composite Total, Israel Wall Street, Information Technology, IT Services, Software—Infrastructure, Technology (View all Sectors)
Average Analyst Recommendation
Analysts covering Amdocs report their recommendations after researching Amdocs' financial statements, talking to executives and customers, or listening in on Amdocs' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Amdocs. The Amdocs consensus assessment is calculated by taking the average forecast from all of the analysts covering Amdocs.
Financial Strength
Based on the key indicators related to Amdocs' liquidity, profitability, solvency, and operating efficiency, Amdocs is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. Financial strength of Amdocs is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.06260.0757
Significantly Down
Pretty Stable
Asset Turnover0.840.87
Sufficiently Down
Pretty Stable
Gross Profit Margin0.410.3535
Fairly Up
Pretty Stable
Total Current LiabilitiesB1.6 B
Way Down
Slightly volatile
Non Current Liabilities Total1.8 B1.7 B
Sufficiently Up
Slightly volatile
Total Assets4.5 B7.4 B
Way Down
Slightly volatile
Total Current Assets1.9 B2.2 B
Fairly Down
Pretty Stable
Total Cash From Operating Activities560.9 M946 M
Way Down
Slightly volatile
Amdocs' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Amdocs' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amdocs' financial leverage. It provides some insight into what part of Amdocs' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Amdocs' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Amdocs deploys its capital and how much of that capital is borrowed.
Liquidity
Amdocs cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 807.31 M in debt with debt to equity (D/E) ratio of 0.23, which may show that the company is not taking advantage of profits from borrowing. Amdocs has a current ratio of 1.57, which is typical for the industry and considered as normal. Debt can assist Amdocs until it has trouble settling it off, either with new capital or with free cash flow. So, Amdocs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amdocs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amdocs to invest in growth at high rates of return. When we think about Amdocs' use of debt, we should always consider it together with cash and equity.

Net Income

350.55 Million
Amdocs (DOX) is traded on NASDAQ Exchange in USA. It is located in 625 Maryville Centre Drive, Saint Louis, MO, United States, 63141 and employs 29,000 people. Amdocs is listed under IT Consulting & Other Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 10.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amdocs's market, we take the total number of its shares issued and multiply it by Amdocs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amdocs runs under IT Services sector within Information Technology industry. The entity has 116.5 M outstanding shares of which 1.71 M shares are currently shorted by investors with about 2.23 days to cover. Amdocs has about 817.98 M in cash with 822.63 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.74.
Check Amdocs Probability Of Bankruptcy
Ownership Allocation
Amdocs retains a total of 116.5 Million outstanding shares. The majority of Amdocs outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amdocs to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amdocs. Please pay attention to any change in the institutional holdings of Amdocs as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Amdocs Ownership Details

Amdocs Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Amdocs jumping above the current price in 90 days from now is about 38.11%. The Amdocs probability density function shows the probability of Amdocs stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.0272 suggesting Amdocs market returns are sensitive to returns on the market. As the market goes up or down, Amdocs is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Amdocs is significantly underperforming NYSE Composite.
  Odds Below 91.03HorizonTargetOdds Above 91.03
61.47%90 days
 91.03 
38.11%
Based on a normal probability distribution, the odds of Amdocs to move above the current price in 90 days from now is about 38.11 (This Amdocs probability density function shows the probability of Amdocs Stock to fall within a particular range of prices over 90 days) .

Amdocs Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Amdocs that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amdocs' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amdocs' value.
InstituionRecorded OnShares
American Century Companies Inc2023-12-31
M
Morgan Stanley - Brokerage Accounts2023-12-31
1.7 M
Alliancebernstein L.p.2023-12-31
1.7 M
State Street Corporation2023-12-31
1.6 M
Vanguard Group Inc2023-12-31
1.5 M
Brandes Investment Partners & Co2023-12-31
1.4 M
Norges Bank2023-12-31
1.4 M
Wellington Management Company Llp2023-12-31
1.3 M
Principal Financial Group Inc2023-12-31
1.2 M
Fmr Inc2023-12-31
17.5 M
Hhg Plc2023-12-31
6.5 M
View Amdocs Diagnostics

Amdocs Historical Income Statement

Amdocs Income Statement is one of the three primary financial statements used for reporting Amdocs's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Amdocs revenue and expense. Amdocs Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Amdocs' Interest Expense is fairly stable compared to the past year. Interest Income is likely to rise to about 25.7 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 181.9 M in 2024. View More Fundamentals

Amdocs Stock Against Markets

Picking the right benchmark for Amdocs stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Amdocs stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Amdocs is critical whether you are bullish or bearish towards Amdocs at a given time. Please also check how Amdocs' historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Investing Opportunities Now

   

Investing Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module

Amdocs Corporate Directors

Amdocs corporate directors refer to members of an Amdocs board of directors. The board of directors generally takes responsibility for the Amdocs' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Amdocs' board members must vote for the resolution. The Amdocs board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Richard LeFaveIndependent DirectorProfile
John MacDonaldDirectorProfile
Zohar ZisapelIndependent DirectorProfile
Simon OlswangIndependent DirectorProfile

How to buy Amdocs Stock?

Before investing in Amdocs, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Amdocs. To buy Amdocs stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Amdocs. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Amdocs stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Amdocs stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Amdocs stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Amdocs, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.

Already Invested in Amdocs?

The danger of trading Amdocs is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amdocs is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amdocs. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amdocs is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amdocs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amdocs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amdocs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amdocs Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Amdocs Stock analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.18
Dividend Share
1.74
Earnings Share
4.68
Revenue Per Share
41.665
Quarterly Revenue Growth
0.05
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.